Peptide Colour: Orange
In studies of GLP-1RA therapy in individuals with type 2 diabetes, the most frequently reported adverse events tend to involve the gastrointestinal system, with nausea, vomiting, and diarrhea occurring in up to 51%, 19%, and 20% of patients, respectively [44]
Millennium Physicians
2 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in
Fritz Jean-Pierre has performed more than 2,500 bariatric surgeries in his career
Considering an increased thromboembolic risk among patients with diabetes mellitus 153,154,155,156,157 , we propose that physicians should consider prescribing antiplatelet or anticoagulating agents more actively in patients with diabetes mellitus to prevent thromboembolic events and their complications during the COVID-19 pandemic